< Back to previous page
Researcher
Erik Van Limbergen
- Keywords:Medicine
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Radiotherapy (Division)
Member
From1 Oct 2005 → 30 Sep 2018
Publications
1 - 10 of 136
- Importance of the ICRU bladder point dose on incidence and persistence of urinary frequency and incontinence in locally advanced cervical cancer: An EMBRACE analysis(2021)
Authors: Erik Van Limbergen
Pages: 300 - 308Number of pages: 9 - Dose-Volume Effects and Risk Factors for Late Diarrhea in Cervix Cancer Patients After Radiochemotherapy With Image Guided Adaptive Brachytherapy in the EMBRACE I Study(2021)
Authors: Erik Van Limbergen
Pages: 688 - 700Number of pages: 13 - Dose volume histogram constraints in patients with head and neck cancer treated with surgery and adjuvant HDR brachytherapy: A proposal of the head and neck and skin GEC ESTRO Working group(2021)
Authors: Erik Van Limbergen
Pages: 128 - 134Number of pages: 7 - Persistence of Late Substantial Patient-Reported Symptoms (LAPERS) After Radiochemotherapy Including Image Guided Adaptive Brachytherapy for Locally Advanced Cervical Cancer: A Report From the EMBRACE Study(2021)
Authors: Erik Van Limbergen
Pages: 161 - 173Number of pages: 13 - Internal mammary and medial supraclavicular lymph node chain irradiation in stage I-III breast cancer (EORTC 22922/10925): 15-year results of a randomised, phase 3 trial(2020)
Authors: Caroline Weltens, Erik Van Limbergen
Pages: 1602 - 1610Number of pages: 9 - Education and training for image-guided adaptive brachytherapy for cervix cancer-The (GEC)-ESTRO/EMBRACE perspective(2020)
Authors: Erik Van Limbergen
Pages: 827 - 836Number of pages: 10 - A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort(2020)
Authors: Maarten Lambrecht, Karin Haustermans, Gert De Meerleer, Erik Van Limbergen
Number of pages: 15 - Clinical and imaging findings in cervical cancer and their impact on FIGO and TNM staging - An analysis from the EMBRACE study(2020)
Authors: Erik Van Limbergen
Pages: 136 - 141Number of pages: 6 - Radiobiology: Foundation and New Insights in Modeling Brachytherapy Effects(2020)
Authors: Erik Van Limbergen
Pages: 4 - 15Number of pages: 12 - Flemish breast cancer screening programme: 15 years of key performance indicators (2002-2016)(2019)
Authors: Chantal Van Ongeval, Erik Van Limbergen
Number of pages: 13